Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2017-01-04

FDA Approved: QUILLICHEW ER — Supplemental Application (NextWave Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved a supplemental application for Quillichew ER (methylphenidate hydrochloride) from NextWave Pharmaceuticals, resulting in updated labeling for the p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE)